Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 603 for hematology

Edit search filters
  1. Venetoclax, Ixazomib Citrate, And Dexamethasone In Treating Patients With Relapsed Multiple Myeloma

    Rochester, MN

  2. Duvelisib And Nivolumab For The Treatment Of Stage IIB-IVB Mycosis Fungoides And Sezary Syndrome

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia

    Rochester, MN

  4. A Study Of Atezolizumab As Adjuvant Therapy In Participants With Renal Cell Carcinoma (RCC) At High Risk Of Developing Metastasis Following Nephrectomy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of Disulfiram And Chemotherapy In Pancreas Cancer Patients

    Rochester, MN

  6. A Study Of Entrectinib (RXDX-101) For The Treatment Of Patients With Solid Tumors That Have NTRK1/2/3, ROS1, Or ALK Gene Rearrangements

    Scottsdale/Phoenix, AZ

  7. A Study Of CART-TnMUC1 In Patients With TnMUC1-Positive Advanced Cancers

    Scottsdale/Phoenix, AZ

  8. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  9. The Road to Wellness after Breast Cancer

    Rochester, MN

  10. Atezolizumab In Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer